Femtobiomed Inc. (XKON:327610)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,195.00
-5.00 (-0.23%)
At close: Jan 30, 2026
-62.80%
Market Cap18.44B -58.4%
Revenue (ttm)389.96M -1.4%
Net Income-1.21B
EPS-876.00
Shares Out8.54M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume473
Average Volume802
Open2,200.00
Previous Close2,200.00
Day's Range2,010.00 - 2,200.00
52-Week Range1,294.00 - 6,390.00
Beta0.70
RSI35.39
Earnings Daten/a

About Femtobiomed

Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform. The company, through its platform, CELLSHOT, is working on cell-based therapeutic pipelines. Its platform provides unprecedented approaches to cell therapeutics and cell biology research. The company was founded in 2011 and is based in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2011
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 327610
Full Company Profile

Financial Performance

Financial Statements